Literature DB >> 15887855

Growth hormone secretion in primary and secondary hyperparathyroidism.

E Cecconi1, M Gasperi, M Genovesi, F Bogazzi, L Grasso, M Procopio, C Marcocci, A Pinchera, L Bartalena, E Martino.   

Abstract

Primary hyperparathyroidism (PHP) is associated with impaired GH secretion. Whether this effect is due to hypercalcemia or to increased serum PTH concentration is unclear. However, patients with familial hypocalciuric hypercalcemia (FHH), who have normal PTH and increased serum calcium concentrations, also have an impaired GH secretion, suggesting that calcium rather than PTH is responsable for this effect on GH secretion. To further investigate this issue, 10 consecutive patients with secondary hyperparathyroidism (SHP) due to vitamin D deficiency were evaluated by the GH response to GHRH+arginine (Arg) test. A group of 60 consecutive untreated PHP patients served as controls. Mean GH response to GHRH+Arg test was 15.8+/-14 microg/l and 37.5+/-16 microg/l (p<0.001) in PHP and in SHP patients, respectively. Forty-two out of 60 (70%) PHP patients had a suppressed or blunted GH response, whereas all SHP patients had normal GH response. The results of the present study confirm and extend our previous observations that PHP is associated with an impaired GH secretion in the majority of cases, and indicate that SHP patients have no abnormality of GH secretion. Thus, hypercalcemia rather than increased serum PTH is responsible for the abnormality of GH secretion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887855     DOI: 10.1007/bf03345352

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

Review 1.  Neuroendocrine control of growth hormone secretion.

Authors:  E E Müller; V Locatelli; D Cocchi
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

Review 2.  Dynamic investigation for evaluation of calcium metabolism and parathyroid function.

Authors:  F Cioppi; A Falchetti; L Masi; M L Brandi
Journal:  J Endocrinol Invest       Date:  2003       Impact factor: 4.256

3.  Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

Authors:  G Aimaretti; G Corneli; P Razzore; S Bellone; C Baffoni; E Arvat; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

Review 4.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Authors:  A Giustina; J D Veldhuis
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

5.  Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism.

Authors:  P Miccoli; A Pinchera; G Cecchini; M Conte; C Bendinelli; E Vignali; A Picone; C Marcocci
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

6.  Adenosine 3',5'-monophosphate-dependent protein kinase from bovine anterior pituitary gland. I. Properties.

Authors:  F Labrie; S Lemaire; C Courte
Journal:  J Biol Chem       Date:  1971-12-10       Impact factor: 5.157

7.  Stability of secretory granules containing growth hormone and prolactin from bovine anterior pituitary gland.

Authors:  A Lemay; F Labrie; D Drouin
Journal:  Can J Biochem       Date:  1974-04

8.  Inhibition of anterior pituitary hormone release by infusion of calcium chloride in the rat.

Authors:  J R Sowers; S Walker; E Sollars; J Herzog
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

9.  GH secretion is impaired in patients with primary hyperparathyroidism.

Authors:  M Gasperi; E Cecconi; L Grasso; L Bartalena; R Centoni; G Aimaretti; F Broglio; P Miccoli; C Marcocci; E Ghigo; E Martino
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

10.  Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.

Authors:  Elisabetta Cecconi; Fausto Bogazzi; Filomena Cetani; Lucia Grasso; Claudio Marcocci; Maura Genovesi; Massimo Procopio; Maurizio Gasperi; Aldo Pinchera; Ezio Ghigo; Enio Martino
Journal:  Clin Endocrinol (Oxf)       Date:  2003-11       Impact factor: 3.478

View more
  2 in total

1.  Myocardial systolic strain abnormalities in patients with acromegaly: a prospective color Doppler imaging study.

Authors:  V Di Bello; F Bogazzi; A Di Cori; C Palagi; M G Delle Donne; S Gavioli; E Talini; C Cosci; C Sardella; G Tonti; E Martino; A Balbarini; M Mariani
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

2.  Impairment of GH secretion in amyotrophic lateral sclerosis is not affected by riluzole treatment.

Authors:  L L Morselli; P Bongioanni; M Genovesi; R Licitra; B Rossi; L Murri; F Bogazzi; E Cecconi; E Martino; M Gasperi
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.